Avinger (NASDAQ:AVGR) Now Covered by Analysts at Wall Street Zen

Equities researchers at Wall Street Zen initiated coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

AVGR opened at $0.47 on Wednesday. The stock has a fifty day simple moving average of $0.47 and a two-hundred day simple moving average of $0.60. The company has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. Avinger has a 12-month low of $0.36 and a 12-month high of $3.04.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.